VaramirStart free · no cardSign in
ALEC as of Oct 31 · 18:10 ET
ALECNasdaqBiological Products, (No Diagnostic Substances)

Alector, Inc. · Brief

Next report

5 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±40.3%
avg realized
±17.3%
Feb 26 '25±46.2%▼−3.49%×0.08
May 8 '25±36.4%▲+12.50%×0.34
Aug 7 '25±37.1%▲+47.26%×1.27
Q3 FY25±37.8%▼−49.84%×1.32
Nov 6 '25±80.9%▼−1.54%×0.02
Q1 FY26±31.5%▲+7.11%×0.23
May 7 '26±13.1%▼−13.93%×1.07
Q2 FY26±39.7%▼−2.73%×0.07
quarterimplied−85%0+85%realized×
Q2 FY26±39.7%▼−2.73%×0.07
May '26±13.1%▼−13.93%×1.07
Q1 FY26±31.5%▲+7.11%×0.23
Nov '25±80.9%▼−1.54%×0.02
Q3 FY25±37.8%▼−49.84%×1.32
Aug '25±37.1%▲+47.26%×1.27
2 older reports
May '25±36.4%▲+12.50%×0.34
Feb '25±46.2%▼−3.49%×0.08
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

3disclosed supplier and customer relationships named in SEC filingsSEC filings
3tracked funds holding ALECN-PORT · Aug 31 '26

Bear2 of 3

5 of 8recent reports where the move came in under the options implied rangeEarnings history
4 of 25largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ALEC report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±59.5% into Nov 5 earnings (Oct 22 close).Source
Oct 168-KMaterial agreement: underwriting agreement with Morgan Stanley & Co. LLC and BTIG, LLC (collectively, the "Underwriters").Source
Oct 58-KMaterial agreement: License Agreement with Genentech, Inc.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.